A survey on chronic rhinosinusitis: opinions from experts of 50 countries

Basit Öğe Kaydı
dc.contributor.authorPassali, Desiderio
dc.contributor.authorCingi, Cemal
dc.contributor.authorCambi, Jacopo
dc.contributor.authorPassali, Francesco
dc.contributor.authorMuluk, Nuray Bayar
dc.contributor.authorBellussi, Maria Luisa
dc.date.accessioned2020-06-25T18:16:25Z
dc.date.available2020-06-25T18:16:25Z
dc.date.issued2016
dc.departmentKırıkkale Üniversitesi
dc.descriptionCambi, Jacopo/0000-0002-5226-2278
dc.description.abstractChronic rhinosinusitis (CRS) is a very prevalent inflammatory disease. Treatments vary in different countries. In the present study, we explored the approaches of physicians in 50 countries. In this cross-sectional study, a rhinosinusitis survey (RSS) was completed by Honorary and Corresponding Members (otorhinolaryngologists) of the Italian Society of Rhinology. In 79.1 % of the 50 countries, the proportion of patients suffering from CRS was 15 %. Nasal symptoms were more intense in winter (46 % of countries), and spring and autumn (22 %). The most common symptoms were nasal obstruction (86 %), postnasal drip (82 %) and headache (52 %). The most common investigative modalities in the assessment of CRS are paranasal sinus CT, fiberoptic endoscopy, and anterior rhinoscopy. CRS patients were principally treated by otorhinolaryngologists (70 %). Medical treatments included nasal corticosteroids (90 %), nasal washes (68 %), and nasal decongestants (32 %). In 88 % of countries, more than 50 %, or "about 50 %", of all patients reported subjective symptom improvement after treatment. In most of the countries, surgery was required by 20-35 % of all CRS patients. During post-surgery follow-up, nasal washes (90 %), nasal corticosteroids (76 %), and systemic antibiotics (32 %) were prescribed. In 20-40 % of all patients, CRS was associated with nasal polyps. In such patients, the medical treatment options were nasal corticosteroids (90 %), systemic corticosteroids (50 %), nasal washes (46 %), and systemic antibiotics (34 %). Treatment of CRS patients varies in different countries. Paranasal sinus CT is the most common investigative modality in the assessment of CRS, and nasal corticosteroids are the first-line treatment, in the absence or presence of nasal polyps.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1007/s00405-015-3880-6
dc.identifier.endpage2109en_US
dc.identifier.issn0937-4477
dc.identifier.issn1434-4726
dc.identifier.issue8en_US
dc.identifier.pmid26742909
dc.identifier.scopus2-s2.0-84953394636
dc.identifier.scopusqualityQ1
dc.identifier.startpage2097en_US
dc.identifier.urihttps://doi.org/10.1007/s00405-015-3880-6
dc.identifier.urihttps://hdl.handle.net/20.500.12587/6520
dc.identifier.volume273en_US
dc.identifier.wosWOS:000379255600019
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Archives Of Oto-Rhino-Laryngology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic rhinosinusitis (CRS)en_US
dc.subjectChronic rhinosinusitis with nasal polyps (CRSwNP)en_US
dc.subjectChronic rhinosinusitis without nasal polyps (CRSsNP)en_US
dc.subjectTreatmenten_US
dc.subjectCountriesen_US
dc.subjectOtorhinolaryngologisten_US
dc.titleA survey on chronic rhinosinusitis: opinions from experts of 50 countriesen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
s00405-015-3880-6.pdf
Boyut:
939.12 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu